These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 7654480)
1. Absorption of cyclosporin from conventional and new microemulsion oral formulations in liver transplant recipients with external biliary diversion. Trull AK; Tan KK; Tan L; Alexander GJ; Jamieson NV Br J Clin Pharmacol; 1995 Jun; 39(6):627-31. PubMed ID: 7654480 [TBL] [Abstract][Full Text] [Related]
2. Cyclosporin. A review of the pharmacokinetic properties, clinical efficacy and tolerability of a microemulsion-based formulation (Neoral). Noble S; Markham A Drugs; 1995 Nov; 50(5):924-41. PubMed ID: 8586033 [TBL] [Abstract][Full Text] [Related]
3. A new microemulsion formulation of cyclosporin: pharmacokinetic and clinical features. Friman S; Bäckman L Clin Pharmacokinet; 1996 Mar; 30(3):181-93. PubMed ID: 8882300 [TBL] [Abstract][Full Text] [Related]
4. Enhanced absorption of new oral cyclosporin microemulsion formulation, Neoral, in liver transplant recipients with external biliary diversion. Trull AK; Tan KK; Tan L; Alexander GJ; Jamieson NV Transplant Proc; 1994 Oct; 26(5):2977-8. PubMed ID: 7940939 [No Abstract] [Full Text] [Related]
5. Cyclosporin: an updated review of the pharmacokinetic properties, clinical efficacy and tolerability of a microemulsion-based formulation (neoral)1 in organ transplantation. Dunn CJ; Wagstaff AJ; Perry CM; Plosker GL; Goa KL Drugs; 2001; 61(13):1957-2016. PubMed ID: 11708766 [TBL] [Abstract][Full Text] [Related]
6. Cyclosporin microemulsion (Neoral). A pharmacoeconomic review of its use compared with standard cyclosporin in renal and hepatic transplantation. Coukell AJ; Plosker GL Pharmacoeconomics; 1998 Dec; 14(6):691-708. PubMed ID: 10346420 [TBL] [Abstract][Full Text] [Related]
7. Bile-independent absorption of cyclosporine from a microemulsion formulation in liver transplant patients. Mueller EA; Kallay Z; Kovarik JM; Richard F; Wiesinger O; Schmidt K; Scheele J Transplantation; 1995 Sep; 60(5):515-7. PubMed ID: 7676504 [TBL] [Abstract][Full Text] [Related]
8. Microemulsion technology in the reformulation of cyclosporine: the reason behind the pharmacokinetic properties of Neoral. Ritschel WA Clin Transplant; 1996 Aug; 10(4):364-73. PubMed ID: 8884110 [TBL] [Abstract][Full Text] [Related]
9. Randomized trial of cyclosporine microemulsion (neoral) versus conventional cyclosporine in liver transplantation: MILTON study. Multicentre International Study in Liver Transplantation of Neoral. Otto MG; Mayer AD; Clavien PA; Cavallari A; Gunawardena KA; Mueller EA Transplantation; 1998 Dec; 66(12):1632-40. PubMed ID: 9884251 [TBL] [Abstract][Full Text] [Related]
10. Microemulsion formulation of cyclosporine in pediatric liver transplantation. Alberti D; Wallemacq P; Falchetti D; de Ville de Goyet J; Rigamonti W; Panzali A; Sokal E; Otte JB; Reding R Transplantation; 1996 Feb; 61(3):512-4. PubMed ID: 8610371 [TBL] [Abstract][Full Text] [Related]
11. Influence of bile on cyclosporin absorption from microemulsion formulation in primary liver transplant recipients. Winkler M; Ringe B; Oldhafer K; Kattner A; Färber L; Maibücher A; Wonigeit K; Pichlmayr R Transpl Int; 1995; 8(4):324-6. PubMed ID: 7546157 [TBL] [Abstract][Full Text] [Related]
12. Absorption characteristics of a microemulsion formulation of cyclosporine in de novo pediatric liver transplant recipients. Dunn SP; Cooney GF; Kulinsky A; Falkenstein K; Pierson A; Elder CA; Meligeni J Transplantation; 1995 Dec; 60(12):1438-42. PubMed ID: 8545871 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of a new oral formulation of cyclosporine in liver transplant recipients. Freeman D; Grant D; Levy G; Rochon J; Wong PY; Altraif I; Asfar S Ther Drug Monit; 1995 Jun; 17(3):213-6. PubMed ID: 7624915 [TBL] [Abstract][Full Text] [Related]
15. Population pharmacokinetic model to predict steady-state exposure to once-daily cyclosporin microemulsion in renal transplant recipients. Schädeli F; Marti HP; Frey FJ; Uehlinger DE Clin Pharmacokinet; 2002; 41(1):59-69. PubMed ID: 11825097 [TBL] [Abstract][Full Text] [Related]
16. Consistent absorption of cyclosporine from a microemulsion formulation assessed in stable renal transplant recipients over a one-year study period. Wahlberg J; Wilczek HE; Fauchald P; Nordal KP; Heaf JG; Olgaard K; Hansen JM; Lokkegaard H; Mueller EA; Kovarik JM Transplantation; 1995 Oct; 60(7):648-52. PubMed ID: 7570970 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of oral cyclosporine (Neoral) in heart transplant recipients during the immediate period after surgery. Banner NR; David OJ; Leaver N; Davis J; Breen J; Johnston A; Yacoub MH Transpl Int; 2002 Dec; 15(12):649-54. PubMed ID: 12478413 [TBL] [Abstract][Full Text] [Related]
18. Effect of gastrointestinal inflammation and age on the pharmacokinetics of oral microemulsion cyclosporin A in the first month after bone marrow transplantation. Schultz KR; Nevill TJ; Balshaw RF; Toze CL; Corr T; Currie CJ; Strong DK; Keown PA Bone Marrow Transplant; 2000 Sep; 26(5):545-51. PubMed ID: 11019845 [TBL] [Abstract][Full Text] [Related]
19. Substitution of conventional cyclosporin with a new microemulsion formulation in renal transplant patients: results after 1 year. Neumayer HH; Färber L; Haller P; Kohnen R; Maibücher A; Schuster A; Vollmar J; Budde K; Waiser J; Luft FC Nephrol Dial Transplant; 1996 Jan; 11(1):165-72. PubMed ID: 8649628 [TBL] [Abstract][Full Text] [Related]
20. Relative bioavailability of cyclosporin from conventional and microemulsion formulations in heart-lung transplant candidates with cystic fibrosis. Tan KK; Trull AK; Uttridge JA; Wallwork J Eur J Clin Pharmacol; 1995; 48(3-4):285-9. PubMed ID: 7589056 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]